Astra Wealth Partners’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$230K Buy
8,228
+180
+2% +$5.07K 0.12% 96
2026
Q1
$230K Hold
8,048
0.14% 83
2025
Q4
$318K Hold
8,048
0.19% 74
2025
Q3
$284K Hold
8,048
0.19% 73
2025
Q2
$264K Hold
8,048
0.2% 72
2025
Q1
$260K Hold
8,048
0.24% 63
2024
Q4
$246K Buy
+8,048
New +$259K 0.23% 63

Other funds holding ATRC

Astra Wealth Partners's ATRC Position: Q2 2026 in Review

Astra Wealth Partners increased its AtriCure (ATRC) stake by 2.2% in Q2 2026, buying an estimated $5.07K and bringing the position to 8,228 shares worth $230K. The position accounts for 0.12% of the portfolio, ranked #96.

Astra Wealth Partners first reported a position in ATRC in Q4 2024 and has held it in 7 quarters since. The position peaked at $318K in Q4 2025. 252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Astra Wealth Partners held 8,228 shares of AtriCure worth $230K as of Q2 2026.
  • Astra Wealth Partners bought 180 AtriCure shares in Q2 2026, an estimated $5.07K.
  • AtriCure made up 0.12% of Astra Wealth Partners's portfolio in Q2 2026, its #96 holding.
  • Astra Wealth Partners first reported a position in AtriCure in Q4 2024 and has held it in 7 quarters since.
  • Astra Wealth Partners's AtriCure position peaked at $318K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Astra Wealth Partners's 13F filing for Q2 2026, filed 11 Aug 2026.